Literature DB >> 470188

Establishment and characterization of a human neuroblastoma cell line in tissue culture.

M Sekiguchi, T Oota, K Sakakibara, N Inui, G Fujii.   

Abstract

A new continuous cell line, GOTO, has been established in tissue culture from a human neuroblastoma arising from the adrenal and maintained for 5 years. The cells are small and fibroblast-like, and grow in dense layer. Population doubling time was approximately 48 hr. The modal chromosome number was near-diploid. Neither marker chromosomes nor double-minute chromosomes were abserved. Inoculum of 10(7) cells produced tumors in ATS-treated hamsters and athymic nude mice, and the histological appearance of tumors was consistent with undifferentiated neuroblastoma. Neural features of the cells were also confirmed by ultrastructural examination. Biochemical analysis showed this cell line to be cholinergic. Morphological differentiation leading to neurite formation was induced by cultivation in serum-free medium.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 470188

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


  14 in total

1.  Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells.

Authors:  Yoshitaka Miyagawa; Hajime Okita; Hideki Nakaijima; Yasuomi Horiuchi; Ban Sato; Tomoko Taguchi; Masashi Toyoda; Yohko U Katagiri; Junichiro Fujimoto; Jun-Ichi Hata; Akihiro Umezawa; Nobutaka Kiyokawa
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

2.  Effects of dibutyryl cAMP and bromodeoxyuridine on expression of N-acetylglucosaminyltransferases III and V in GOTO neuroblastoma cells.

Authors:  Y Ihara; A Nishikawa; N Taniguchi
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

3.  Two species of human CRK cDNA encode proteins with distinct biological activities.

Authors:  M Matsuda; S Tanaka; S Nagata; A Kojima; T Kurata; M Shibuya
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

4.  Expression of neural cell adhesion molecule (NCAM) isoforms in neuroblastoma.

Authors:  E Phimister; F Kiely; J T Kemshead; K Patel
Journal:  J Clin Pathol       Date:  1991-07       Impact factor: 3.411

5.  A cranial invasion model of human neuroblastoma using congenitally athymic mice.

Authors:  K Yoshida; G Yoshizawa; Y Yamazaki; T Fujikawa; A Tanabe; K Sakurai
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.

Authors:  T Matsui; K Sano; T Tsukamoto; M Ito; T Takaishi; H Nakata; H Nakamura; K Chihara
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  A monoclonal antibody specifically reactive with Ewing's sarcoma.

Authors:  S Hara; E Ishii; S Tanaka; J Yokoyama; K Katsumata; J Fujimoto; J Hata
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

8.  Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation and cytogenetic abnormalities.

Authors:  N Esumi; S Imashuku; K Tsunamoto; S Todo; S Misawa; T Goto; Y Fujisawa
Journal:  Jpn J Cancer Res       Date:  1989-05

9.  HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells.

Authors:  Xiuru Zhang; Jun-ichi Hamada; Arata Nishimoto; Yoko Takahashi; Taichi Murai; Mitsuhiro Tada; Tetsuya Moriuchi
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

10.  Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.

Authors:  Naoko Mise; Mariko Takami; Akane Suzuki; Toshiko Kamata; Kazuaki Harada; Tomoro Hishiki; Takeshi Saito; Keita Terui; Tetsuya Mitsunaga; Mitsuyuki Nakata; Takayuki Ikeuchi; Toshinori Nakayama; Hideo Yoshida; Shinichiro Motohashi
Journal:  Cancer Sci       Date:  2016-02-09       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.